L-glutamine use in adults with sickle cell disease: Clinical trials where success meets reality

被引：9
|
作者：
Ogu, Ugochi O. [1 ,2 ]
Thomas, Merin [1 ]
Chan, Florence [3 ,4 ]
Vattappally, Leena [1 ]
Sebastian, Gracy [1 ]
Crouch, Andrew [1 ]
You, Shuo [1 ]
Minniti, Caterina P. [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Hematol, Bronx, NY 10467 USA
[2] Univ Tennessee, Ctr Hlth Sci, Ctr Sickle Cell Dis, Memphis, TN 38163 USA
[3] LeMed Specialty Pharm, Bronx, NY USA
[4] Vivo Hlth Specialty Pharm, New Hyde Pk, NY USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2021年 / 96卷 / 01期
关键词：
D O I：
10.1002/ajh.26021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：E38 / E40
页数：4
相关论文
共 50 条
  • [21] L-glutamine, crizanlizumab, voxelotor, and cell-based therapy for adult sickle cell disease: Hype or hope?
    Leibovitch, Jennifer N.
    Tambe, Ajay, V
    Cimpeanu, Emanuela
    Poplawska, Maria
    Jafri, Firas
    Dutta, Dibyendu
    Lim, Seah H.
    BLOOD REVIEWS, 2022, 53
  • [22] Pediatric Patients with Sickle Cell Disease at Harbor-UCLA & Early Experience of L-Glutamine Therapy
    Gotesman, Moran
    Elgar, Guy
    Pak, Youngju
    Santiago, Laura Hernandez
    Alvarez, Abigail
    Lin, Henry
    Lasky, Joseph L., III
    Panosyan, Eduard H.
    BLOOD, 2020, 136
  • [23] Potential causal role of L-glutamine in sickle cell disease painful crises: A Mendelian randomization analysis
    Ilboudo, Yann
    Garrett, Melanie E.
    Bartolucci, Pablo
    Brugnara, Carlo
    Clish, Clary B.
    Hirschhorn, Joel N.
    Galacteros, Frederic
    Ashley-Koch, Allison E.
    Telen, Marilyn J.
    Lettre, Guillaume
    BLOOD CELLS MOLECULES AND DISEASES, 2021, 86
  • [24] L-glutamine therapy improves minute ventilation of sickle cell anemia patients
    Macan, Henry R.
    Porszasz, Janos
    Tsurugaya, Hideki
    Razon, Rafael L.
    Koh, Han
    Casaburi, Richard
    Tanaka, Kouichi R.
    Niihara, Yutaka
    BLOOD, 2007, 110 (11) : 13B - 13B
  • [25] A Phase 3 Study of L-Glutamine Therapy for Sickle Cell Anemia and Sickle β0-Thalassemia
    Niihara, Yutaka
    Koh, Han A.
    Tran, Lan
    Razon, Rafael
    Macan, Henry
    Stark, Charles
    Wun, Ted
    Adams-Graves, Patricia
    BLOOD, 2014, 124 (21)
  • [26] Safety Profile of L-Glutamine in Patients with Sickle Cell Disease: Data from Post-Marketing Surveillance
    Rastogi, Bhawna
    Rani, Sunita
    Mayuzumi, Meiko
    Razon, Rafael
    Singh, Rajani
    Goodrow, Jason
    Becerra, Joseph M.
    Stark, Charles W.
    Niihara, Yutaka
    BLOOD, 2021, 138
  • [27] TREATMENT STRATEGIES IN CHILDREN WITH SEVERE SICKLE CELL DISEASE AFTER THE INTRODUCTION OF L-GLUTAMINE POWDER: A DECISION ANALYSIS
    Yunusa, I
    Ndikumukiza, C.
    Eguale, T.
    VALUE IN HEALTH, 2018, 21 : S253 - S253
  • [28] Measuring success: utility of biomarkers in sickle cell disease clinical trials and care
    Kalpatthi, Ram
    Novelli, Enrico M.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2018, : 482 - 492
  • [29] A Population Pharmacokinetic Analysis of l-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects
    Alina Sadaf
    Min Dong
    Amanda Pfeiffer
    Teresa Latham
    Theodosia Kalfa
    Alexander A. Vinks
    Russell E. Ware
    Charles T. Quinn
    Clinical Pharmacokinetics, 2024, 63 : 357 - 365
  • [30] Systematic Review of l-glutamine for Prevention of Vaso-occlusive Pain Crisis in Patients with Sickle Cell Disease
    Cieri-Hutcherson, Nicole E.
    Hutcherson, Timothy C.
    Conway-Habes, Erin E.
    Burns, Brianna N.
    White, Nathan A.
    PHARMACOTHERAPY, 2019, 39 (11): : 1095 - 1104
12345